In the PPMI cohort, amongst patients with sporadic PD (negative for GBA mutations), patients with higher CSF glucocerebrosidase-to-sphingomyelin ratios showed faster cognitive decline over 3 years, although the ratio did not show significant longitudinal changes191. The gene discussed is GBA1; the disease is Parkinson disease.